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Abstract 13 
BACKGROUND: The origin of tinnitus has been attributed to a peripheral auditory lesion, 14 
inducing bottom-up changes and resulting in the perception of a ‘phantom sound’. However, 15 
non-auditory factors can co-exist as well, and can even lie at the origin of tinnitus 16 
development. An increasing body of literature focuses on psychological, (neuro)muscular, 17 
cardiovascular and many other influences and their respective associations with tinnitus 18 
prevalence. OBJECTIVE OF REVIEW: The purpose of this study is to provide a 19 
comprehensive description of these non-otologic risk factors, and to summarize the evidence 20 
in literature about their link with tinnitus.TYPE OF REVIEW: A narrative systematic review 21 
was conducted, following the Preferred Reporting Items for Systematic reviews and Meta-22 
Analyses statement.SEARCH STRATEGY: The MEDLINE, Embase, and Web of Science 23 
databases were systematically searched for eligible articles, supplemented with manual 24 
search methods and grey literature search.Epidemiological studies reporting on the 25 
relationship between various non-otologic risk factors and tinnitus were included. 26 
EVALUATION METHOD: Quality assessment was performed using the Hoy & Brooks 27 
tool.RESULTS: Fifty-five studies were included. Studies were of variable quality, with poor 28 
tinnitus definitions and evaluations or questionable sampling of the study population as main 29 
contributing factors for high risk of bias. Multiple associated factors have been identified, 30 
including cardiovascular, psychological, neurological, musculoskeletal, and dietary factors. 31 
CONCLUSIONS:The current literature review identified multiple risk factors that could be 32 
of significant importance for tinnitus development, maintenance or 33 
aggravation.Whilecausality remains uncertain, this systematic elaboration of possible tinnitus 34 
comorbidities/risk factors can help provide direction for future research, and can direct 35 
clinicians to identify patients at risk and treat relevant symptoms accordingly. 36 
 37 
Key Words: Tinnitus, review, epidemiology, etiology,pathophysiology, diagnosis, therapy  38 
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Introduction 39 
Tinnitus, or the conscious perception of a meaningless sound without an external 40 
acoustic stimulationis a prevalent phenomenon.
1
It is described in approximately 5.1-42.7% of 41 
the general population, with a debilitating form reported in approximately 5.7%.
2
 42 
The pathophysiological mechanism of tinnitus is complex and not fully unraveled.
3-6
The 43 
general hypothesis links tinnitus to a peripheral auditory lesion (e.g. hearing loss, infection, 44 
trauma or surgery), inducing bottom-up changes in the central neurological system due to 45 
dynamic neuroplasticity.
3,7,8
Modifications in non-auditory regions are stated to be responsible 46 
for emotional and attentional processing of the tinnitus perceipt, while changes in the 47 
auditory network result in the perceptual aspects of the tinnitus.
9-12
 48 
These diverse changes at the level of the peripheral and central auditory pathway 49 
result in a very heterogeneous tinnitus population, which poses a great clinical challenge 50 
concerning tinnitus diagnosis, prevention and treatment.
13,14
This heterogeneity impairs the 51 
development of uniform treatment strategies
15
; with most of the currently proposed therapies 52 
showing variable effectiveness in this large patient group.
16-18
 53 
The pathophysiological involvement of non-auditory structures and the possible effect 54 
of non-otologic treatment approaches, support the need to further elaborate the role of non-55 
otologic factors in tinnitus development and maintenance. Hence, the aim of the current study 56 
was to collect and critically assess all non-otologic risk factors described in association with 57 
tinnitus complaints. The results can expose gaps in current literature to guide future research 58 
on the one hand, and on the other hand, provide a valuable tool for clinicians. Taking into 59 
account non-otologic factors in the diagnosic and therapeutic workup of an individual tinnitus 60 
patient, could lead to a more holistic view of the patient, prevention of further detoriation and 61 
even to more effective therapeutic approaches, working towards personalized medicine.  62 
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Materials and methods 63 
This systematic review was performed according to the Preferred Reporting Items for 64 
Systematic Reviews (PRISMA) statement.
19
The PRISMA flow diagram, describing the 65 
literature search and selection progress, can be found in Appendix A. The review protocol 66 
was preregistered by use of the international prospective register of systematic reviews 67 
(PROSPERO, http://www.crd.york.ac.uk/PROSPERO), under registration number 68 
CRD42017080568. 69 
 70 
Eligibility criteria 71 
The review objective was to select all cohort or cross-sectional studies concerning 72 
adult patients, primarily diagnosed with tinnitus, and who were screened for the co-73 
occurrence of one or more non-otologic risk factors. Exclusion criteria were: - tinnitus not 74 
primary diagnosis (part of other syndrome/disease); -no cohort or cross-sectional study; -75 
focus on otologic factors (hearing loss, dizziness,…); -focus on tinnitus diagnostic criteria, 76 
prevalence figures, pathophysiology, therapy or influence on daily life; -studies involving 77 
children or investigating heritability. No restrictions were applied concerning publication 78 
date. Only articles written in English were selected. 79 
 80 
Search strategy 81 
The following databases were systematically searched for eligible articles by two 82 
authors independently (A.D. & J.D.): MEDLINE, Embase, and Web of Science. Additional 83 
literature was retrieved by screening the reference lists of relevant articles. Grey literature 84 
(unpublished) was searched for using ClinicalTrials.gov (https://clinicaltrials.gov/). The last 85 
search was performed on March 23
rd
 2019. Appendix B illustrates the applied search terms 86 
for each database. Because our search domain was very broad, covering all non-otologic risk 87 
factors, we decided to only apply ‘MeSH’ terms in the MEDLINE database, and not perform 88 
additional searches using free text words.  89 
 90 
Study selection 91 
Two authors (A.D. and J.D.) performed the literature search and study selection 92 
independently (Appendix A). Differences in opinion between the two authors were resolved 93 
by discussion.  94 A
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If multiple publications were available from the same study or dataset, all publications that 95 
met the inclusion criteria were included, unless there was an overlap in results: then, only the 96 
most complete (usually most recent) report was selected. 97 
 98 
Data extraction 99 
The data extraction form was developed by two authors (A.D. and J.D.) and piloted 100 
on a random selection of five included studies. Again, any discrepancies in data extracted by 101 
the two authors, were resolved by discussion. 102 
 103 
Risk of bias evaluation 104 
Quality assessment was performed independently by two authors (A.D. and J.D.), 105 
using the Hoy & Brooks tool.
20
This consists of 10 items, investigating external (selection of 106 
study population and nonresponse bias) and internal (measurement bias, analysis-related bias) 107 
validity. By inclusion of a summarizing general 11
th
 item, an overall evaluation of the risk of 108 
bias can be given, taking into account the scores on the previous 10 items
20
(Appendix C).We 109 
chose to assign a ‘low’ risk of bias to studies which scored positively on 7 or more items; a 110 
‘moderate’ risk of bias was assigned to studies with 5 or 6 positive items; whereas a ‘high’ 111 
risk of bias was given to studies which complied with 4 or less items of the tool. It should be 112 
noted that these values are chosen arbitrarily and that the Hoy&Brooks tool does not provide 113 
a direct/numeric measure of the presence or absence of bias in a study. Instead, it is designed 114 
to give multi-faceted information on the way a study tried to attempt minimizing bias.
20
 115 
Inconsistencies in quality evaluation between the two reviewers were resolved through 116 
discussion.  117 
 118 
Results 119 
Search results 120 
Table 1 summarizes the study characteristics of the included studies (n = 55, 121 
Appendix A) and the risk factors that were investigated. Fifteen includedstudies were cohort 122 
studies, while a total of 40 used the cross-sectional study design.Tables 2-6 summarize the 123 
studies  risk factor categories and depict if an association (positive or negative) was found or 124 
not. There are several studies that made use of the same data source (often national surveys, 125 
epidemiological data); e.g. 6 publications analyzed data from the Korean National Health and 126 
Nutrition Examination Survey.
21-26
All of these studies were included because each 127 A
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manuscript analyzed different risk factors, or analyzed another cohort from the same 128 
epidemiological database.A list of excluded studies is provided in Appendix D. 129 
 130 
Risk of bias assessment 131 
A detailed score for each evaluation item is provided in Appendix C. Five studies 132 
were evaluated as having a high risk of bias (4 or less checked items of the tool).
22,27-30
These 133 
studies mainly scored low for adequate tinnitus defining (i.e. no specification of duration, 134 
continuous/intermittent/pulsatile complaints…), use of standardized evaluation methods (i.e. 135 
validated questionnaires), and quality of sampling of the study population (i.e. random 136 
selection, representation of the national or target population,…).   137 
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Summary of main results 138 
 A ‘general’ risk factor was defined as a nonmedical or demographic risk factor 139 
specific to the patient his/her context. A total of 34 manuscripts described the impact of 140 
‘general’ risk factors on tinnitus.Age was researched in a total of 29 manuscript, of which 18 141 
describe a positive correlation between advanced age and an increased risk of tinnitus. In 142 
contrast, the differences in gender weremore heterogeneous; in a total of 26 papers, three 143 
describe an increased prevalence in male subjects, six in femalesubject, while 17 describe no 144 
association between gender and tinnitus. Other risk factors as marital status (n=8), 145 
educational status (n=14), rural/urban environment (n=4) or ethnicity (n=3) also display 146 
ambiguous results.The discrepancies in these results might be the result of differences in local 147 
wealth and wellbeing, including social and working environment,.The impact of 148 
unemployment (n=4), economic status (n=5), bilateral handedness (n=1) and family history 149 
of tinnitus (n=2) all display a general positive correlation. However, thesefactors are only 150 
mentioned in a limited amount of studies. 151 
 A total of 28 manuscripts describecardiovascular risk factors, defined as risk 152 
factors both directly and indirectly associated with diseases of the cardiovascular system, co-153 
occuring with tinnitus(Table 3). Measures of (increased risk of developing) cardiovascular 154 
diseases, such as hypertension (n=20),dyslypidemia (n=13), peripheral vascular disease and 155 
ischemic heart disease (n=11) and transient ischemic attack/stroke (n=8) are described with a 156 
variable association with tinnitus. Interestingly, Gibrin et al. only describe an increased 157 
association with tinnitus when both hypertension and diabetes are present in the patient, 158 
displaying the importance of multimorbidity.
31
Other cardiovascular risk factors considered 159 
arepulse pressure, obesity, dyslipidemia, diabetes/elevated fasting glucose, smoking and lack 160 
of physical exercise. As illustrated in Table 3, no consensus concerning the influence on 161 
tinnitus prevalence for any of these factors could be established. Dietary risk factors were 162 
defined as risk factors associated with the dietary intake of the patients with no specific 163 
cardiovascular or psychiatric correlation. Two studies describe an inverse relation between 164 
caffeine intake and tinnitus prevalence.
32,33
 McCormack et al.
33
andSpankovich et al.
34
report 165 
contradictory results concerning influence of other dietary factors on tinnitus: whereas the 166 
first author linked the intake of vegetables/fruit and wholemeal products to an increase in 167 
tinnitus complaints, the second advices a healthy diet in the management of tinnitus. 168 
Psychological risk factorswere defined as risk factors associated with the 169 
psychological wellbeing of the patient (Table 4). A total of 25 manuscripts described the 170 
effect of psychological disorder on the presence of tinnitus. The strongest correlation is 171 
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described in patients with depressive symptoms where 13/17 studies found a significantly 172 
positive correlation between depression and tinnitus prevalence. Other characteristics of 173 
psychological distress, such as anxiety (n=4/8), stress (n=3/6), were only found to be 174 
positively associated with tinnitus in 4/8 and 3/6 manuscripts respectively. Moreover, poor 175 
overall quality of sleepwas associated with higher rates of tinnitus in 5/7 manuscripts.  176 
Neurological and musculoskeletalrisk factorswere defined as risk factors directly 177 
or indirectly associated with musculoskeletal and neurologicalpathologies, a total of twenty 178 
manuscripts describing these risk factors were included (Table 5). Headache, including 179 
migraine, head injury and whiplash displayed a significant correlation with tinnitus in 6/8, 6/7 180 
and 3/3 manuscripts, respectively. Interestingly, specific joint problems such 181 
astemporomandibular disorder (TMD), arthritis and more specifically, rheumatoid arthritis 182 
were found to be associated with tinnitus in 7/8, 5/6 and 2/2 manuscripts. 183 
All risk factors not eligible to be included into the forementioned subgroups were 184 
grouped in Table 6 asfactors related to atopyand miscellaneous risk factors. A total of 19 185 
manuscripts were included into this subgroup and were classified into 17 different classes. 186 
Of interest are the rhinological risk factors such as rhinitis and rhinosinusitis which have a 187 
2/2 and 4/5 positivity rate with tinnitus. Other risk factors, such as thyroid disease and 188 
meningitis, among others, are positively correlated, but were both only described in one 189 
individual study . 190 
191 
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Discussion 192 
The current manuscript aimed at collecting all available epidemiological data 193 
pertaining to one or more risk factors for tinnitus, excluding wellknown otologic, audiologic 194 
or ototoxic factors. To the best of our knowledge, this is the first literature review that has 195 
systematically screened relevant publications reporting on the influence of personal, 196 
cardiovascular, psychological, neurological, musculoskeletaland other non-otological factors 197 
on tinnitus prevalence or development. Because of the broad variety in search terms, it was 198 
possible to give a clear and concise overview of all published and unpublished non-otologic 199 
risk factors associated with tinnitus.  200 
As can be seen in the results, multiple risk factors were defined by scientific 201 
studies butfew resulted in significant correlations with tinnitus. These ambivalent 202 
resultsensue difficulties indefining correlations specifically as risk factors. The inconsistent 203 
and incomplete definition of the risk factors in the manuscripts develop a generally 204 
incomparable set of results.Moreover, comparison between different studies is troublesome, 205 
as methodologies are often different and, as shown in appendix C, the quality of the trial itself 206 
is oftentimes questionable. As an example, comparison of the different studies analyzing age 207 
as a risk factor is difficult, as different age groups were studied. In general, age seems to be 208 
an important risk factor but as a result of different reporting methods, specific 209 
characterization of the age on which it becomes a risk factor, remains difficult.
35
 210 
The role of factors associated with cardiovascular diseasesand their co-occurrence 211 
with tinnitus remains a controversial topic. In our results, the included studies correlated 212 
hypertension and diabetes with tinnitus in 10/20 and 11/17 studies respectively, while one 213 
study only found a correlation when both hypertension and diabetes were present.These 214 
results  might suggest a trend that patients with a higher risk for cardiovascular diseases, 215 
might also be at risk for developing tinnitus. This is hypothesis is strengthened by the the role 216 
of smoking and dyslipidemia in respectively 9/15 and 8/13 studies.Recent studies are 217 
correlating the presence of tinnitus in patients with hypertension. 
36,37
However, studies that 218 
demonstrate association of cardiovascular diseases and the presence of tinnitus remain absent.  219 
Tinnitus is frequently accompanied and influenced by psychological factors 220 
and/or psychiatric diseases like stress, sleep difficulties, anxiety and depression.
38
 The current 221 
review confirms this, with most convincing evidence for depression as a risk factor. 222 
However, the question remains whether these psychologic factors have to be considered as 223 
risk factors for tinnitus development, as behavioral patterns resulting from tinnitus burden, or 224 
as part of a complex umbrella pathology with shared pathophysiological features. 225 
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For this review, it was impossible to perform an extensive and in-depth search for 226 
all risk factors and still provide an easy-view summary. The literature search focused on most 227 
relevant literature.Moreover, most included risk factors were only mentioned in a limited 228 
number of manuscripts and analyzed using a cross-sectional methodology. Although this 229 
study design can be very useful to find associations between factors in large study groups, no 230 
causal relationship can be assumed or confirmed. It can only be stated that there is a co-231 
occurrence between two phenomena, without being able to investigate a pathophysiological 232 
link. Case-control studies were excluded as the goal of the current review was to investigate 233 
the population-based risk factors of tinnitus. The main goal of the current systematic review 234 
was to identify risk factors. In order to validate the causality of the currently described risk 235 
factors, a systematic reviewof the literature reporting on the individual subgroups, including 236 
the case-control methodology, might be of interest. 237 
Patients consulting the clinic with a tinnitus complaint, are first screened for 238 
hearing loss or other otologic disease, as these are the most common tinnitus etiologies.
11
 239 
However, it is important that any health care professional is aware of the fact that non-240 
otologic influences can aggravate or even induce a tinnitus perceipt. As previously stated, we 241 
are aware that it is not possible to establish a cause-effect relationship based on cross 242 
sectional studies, and that the above-mentioned data can be considered as either a 243 
coincidental co-occurrence with tinnitus, a consequence of tinnitus burden, or a true 244 
risk/pathophysiological factor for tinnitus generation. In any case, in a presenting tinnitus 245 
patient, it seems primordial to identify as much influencing factors from multiple domains as 246 
possible, to provide a personalized tinnitus treatment and guidance.
13
 Moreover, by treating 247 
e.g. hypertension, depressive thoughts or musculoskeletal disorders, a caregiver can possibly 248 
either minimize tinnitus impact or even interfere with tinnitus generating mechanisms. In 249 
short, tinnitus management should include screening, treatment and/or follow-up of possible 250 
risk factors, includingcardiovascular, psychological, musculuskeletal and atopic 251 
comorbidities. As these factors can interfere with effective tinnitus coping strategies, 252 
clinicians should take additional non-otologic burden into account and arrange proper follow 253 
up for patients at risk.
41 254 
255 
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Conclusions 256 
In conclusion, multiple risk factors have been identified that could be of significant 257 
importance for tinnitus development, maintenance or aggravation. Although causality is 258 
mostly uncertain, these associations can be important for treatment purposes as well as for 259 
identification of individuals at risk for tinnitus development. The results of this review can 260 
help further guide clinicians in an individualized diagnostic and therapeutic approach.Future 261 
research should focus on a prospective design, and should apply rigorous, transparent and 262 
uniform diagnostic criteria for tinnitus as well as the conditions under investigation.  263 
 264 
 265 
 266 
Data availability statement 267 
Data sharing is not applicable to this article as no new data were created or analyzed in this 268 
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Abbreviations 270 
PRISMA Preferred Reporting Items for Systematic Reviews 271 
TMD  Temporomandibular disorder 272 
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 Table legends 273 
Table 1 – Characteristics of the included studies. 
Table 2 – General risk factors 
Table 3 – Cardiovascular risk factors 
Table 4 – Dietary and psychological risk factors 
Table 5 – Neurological and musculoskeletalrisk factors 
Table 6 – Atopic and miscellaneous risk factors 
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Table 1. Characteristics of the included studies.  
M
a
n
u
sc
ri
p
t 
A
u
th
o
rs
 
Y
ea
r 
o
f 
p
u
b
li
ca
ti
o
n
 
L
o
ca
ti
o
n
 
n
 
%
 t
in
n
it
u
s 
(b
a
se
li
n
e)
 
S
tu
d
y
 d
es
ig
n
 
G
en
er
a
l 
C
a
rd
io
v
a
sc
u
la
r 
D
ie
ta
ry
 
P
sy
ch
o
lo
g
ic
a
l 
M
u
sc
u
lo
sk
el
et
a
l 
A
to
p
ic
 
M
is
ce
ll
a
n
eo
u
s 
1 Adoga et al. 2008 Nigeria 687 15.1 Cross sectional       x       
2 Axelsson et al. 1989 Sweden 3600 14.2 Cross sectional x     x       
3 Bernhardt et al.  2004 Germany 4228 3.3 Cross sectional x     x x     
4 Bernhardt et al. 2011 Germany 6104 24.9 Cohort x     x x     
5 Bhatt et al.  2017 USA 
21,4 
mil 
26.1 Cross sectional 
 
  x x 
 
    
6 Borghi et al.  2005 Italy 476 17.6 Cross sectional x x           
7 Borghi et al.  2011 Italy 958 24.3 Cross sectional x x           
8 Chen et al. 2017 Taiwan 79095 20.0 Cohort   x         x 
9 Dorner et al.  2010 Austria 686 10.8 Cross sectional x     x       
10 Engdahl et al.  2012 Norway 49948 12.1 Cohort x             
11 Figueiredo et al. 2016 Brazil 284 78.3 Cross sectional x x x         
12 Folmer et al. 2003 USA 2400 100 Cross sectional         x     
13 Frederiksen et al. 2017 Denmark 544 7.5 Cross sectional       x       
14 Frei et al. 2012 Switzerland 1375 9.3 Cohort             x 
15 Fujii et al.  2011 Japan 14423 11.9 Cohort x x   x   x x A
cc
ep
te
d 
A
rt
ic
le
 This article is protected by copyright. All rights reserved 
16 Gallus et al. 2015 Italy 2952 6.2 Cross sectional x x           
17 Gibrin et al. 2012 Brazil 498 42.8 Cross sectional   x           
18 Glicksman et al. 2014 Canada 65085 0 Cohort     x         
19 Gopinath et al.  2010a Australia 1214 30.3 Cohort x x     x     
20 Gopinath et al.  2010b Australia 1214 37.2 Cohort x             
21 Guichard et al.  2016 France 5729 5.8 Cross sectional   
 
    x     
22 Herr et al. 2016 Germany 1632 13.9 Cross sectional       x       
23 Hilgenberg et al.  2012 Brazil 200 50.0 Cross sectional x     x x     
24 House et al. 2018 USA 1314 29.5 Cohort x x   x       
25 Izuhara et al. 2013 Japan 14027 11.8 Cross sectional       x       
26 Jalessi et al. 2013 Iran 3207 4.6 Cross sectional x             
27 Khedr et al.  2010 Egypt 8484 5.17 Cross sectional x     x x     
28 Kim et al. 2015 Korea 19290 20.7 Cross sectional x x   x x x x 
29 Lasisi et al.  2010 Nigeria 1302 14.1 Cohort x x   x x 
 
x  
30 Lasisi et al.  2011 Nigeria 1302 14.1 Cohort       x       
31 Lee et al.  2016 Taiwan 37925 0 Cohort         x     
32 Lee et al.  2017 South Korea 2736 22.2 Cross sectional x x   x     x 
33 Lin et al. 2018 Taiwan 724735 2.0 Cross sectional x x   x x   x 
34 M, M. Shirazi et al.  2011 Iran 1043 100 Cross sectional   x           
35 McCormack et al.  2014 
United 
Kingdom 
171722 17.3 Cross sectional     x         
36 Michikawa et al.  2010 Japan 1320 18.6 Cross sectional x x   x x    x 
37 Michikawa et al.  2013 Japan 535 16.3 Cohort       x       A
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38 Negrila-Mezei et al. 2011 Romania 471 24.2 Cross sectional x x         x 
39 Nondahl et al.  2010 USA 2922 0 Cohort x x     x     
40 Nondahl et al.  2011 USA 3267 10.6 Cross sectional x x   x x 
 
  
41 Oiticica et al. 2015 Brazil 1960 21.9 Cross sectional x x           
42 Park et al. 2014a Korea 21893 19.7 Cross sectional x x   x   
 
x 
43 Park et al. 2014b Korea 10061 21.4 Cross sectional x x   x x 
 
 x 
44 Park et al. 2018 Korea 12618 23.3 Cross sectional x x   x       
45 Pezzoli et al.  2015 Italy 1251 26.7 Cross sectional x       x     
46 Shargorodsky et al.  2010 USA 14178 25.3 Cross sectional x x   x       
47 Shih et al. 2017 Taiwan 741720 0 Cohort             x 
48 Shiue et al. 2013 USA 10122 33.0 Cross sectional             x 
49 Sindhusake et al.  2003 Australia 1994 uk  Cross sectional x      
 
x   x  
50 Sogebi  2013 Nigeria 543 14.5 Cross sectional x x     x   x 
51 Spankovich et al. 2017 USA 2176 11.7 Cross sectional     x         
52 Spankovich et al. 2018 USA 2015 10.6 Cross sectional   x x   x   x 
53 Sunwoo et al. 2018 Korea 11402 21.5 Cross sectional             x 
54 Swan et al. 2017 USA 507248 13.1 Cross sectional x x   x x   x 
55 Yang et al. 2018 China 3705 10.4 Cross sectional x x   x     x 
 
For each study, it is indicated if they provided data about the different classes of identified non-otologic risk factors. Additional information can 
be found in tables 2-6. 
n = size of study population; uk = unknown A
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Table 2. General risk factors.  
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B
il
a
te
ra
l 
h
a
n
d
ed
n
es
s 
F
a
m
il
ia
l 
h
is
to
ry
  
o
f 
ti
n
n
it
u
s 
2 Axelsson et al. (1989)   + (♂)                 
3 Bernhardt et al. (2004) +                   
4 Bernhardt et al. (2011) + 0   0             
6 Borghi et al. (2005) 
 
+ (♀)                 
7 Borghi et al. (2011) 0 0                 
9 Dorner et al. (2010)   0                 
10 Engdahl et al. (2012) +                   
11 Figueiredo et al. (2016) 0 0           0     
15 Fujii et al. (2011)     0 -             
16 Gallus et al. (2015) + 0 - 0 -           
19 Gopinath et al. (2010a) - 0                 
20 Gopinath et al. (2010b) -                   
23 Hilgenberg et al. (2012)   + (♀)                 
24 House et al. (2018) + + (♀)   - -           
26 Jalessi et al. (2013) +                   
27 Khedr et al. (2010) + 0   -     +   + + 
28 Kim et al. (2015) 0 + (♀) + (nr. -   +         A
cc
ep
te
d 
A
rt
ic
le
 This article is protected by copyright. All rights reserved 
household 
members) 
29 Lasisi et al. (2010) 0 0   0 0   0       
32 Lee et al. (2017) +     - -           
33 Lin et al. (2018) + + (♀)                 
36 Michikawa et al. (2010) 0 0 0 0             
38 
Negrila-Mezei et al. 
(2011) 
+                   
39 Nondahl et al. (2010)   + (♂)                 
40 Nondahl et al. (2011) + 0   0             
41 Oiticica et al. (2015) + + (♀)       +         
42 Park et al. (2014a) + 0 0               
43 Park et al. (2014b) + + (♀)                 
44 Park et al. (2018) +   - - - + 0       
45 Pezzoli et al. (2015) + 0                 
46 
Shargorodsky et al. 
(2010) 
+ 0   -       
+ (white vs 
Hispanic/black) 
    
49 Sindhusake et al. (2003) 0 0                 
50 
Sogebi(2013) 0 0 0 0   
0 
(employment 
class) 
        
54 
Swan et al. (2017) - + (♂) -         
+ (Asian vs 
African 
    A
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American) 
55 Yang et al. (2018) + 0   +     +     + 
 
If a significant association was found, this is indicated by ‘+’(positive association) or ‘-‘ (negative association). Insignificant values (absence of 
association) are marked by ‘0’. If a certain risk factor is not investigated by the respective article, the cell is left blank.  
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Table 3. Cardiovascular risk factors. 
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ia
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H
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se
 /
 
P
er
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h
. 
V
a
sc
. 
D
is
e
a
se
 
T
IA
 &
 S
tr
o
k
e 
E
x
er
ci
se
 
5 Bhatt et al. (2017)         0           
6 Borghi et al. (2005) + - 0       0       
7 Borghi et al. (2011) 0 -           0     
8 Chen et al. (2017) +   +       + + +   
11 Figueiredo et al. (2016) +                   
15 Fujii et al. (2011) +   0 0 0 0   + 0 + 
16 Gallus et al. (2015)       0 - +         
17 Gibrin et al. (2012) 0†   0†               
19 Gopinath et al. (2010a) 0           0       
24 House et al. (2018) + 0 0     0 0     - 
28 Kim et al. (2015) +   + + -   + + +   
29 Lasisi et al. (2010) 0   0 0 0       0   
32 Lee et al. (2017)         - -         
33 Lin et al. (2018) +   +       + + +   
34 M, M. Shirazi et al. (2012)             -       
36 Michikawa et al. (2010) 0   0 0 0     + 0   A
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38 Negrila-Mezei et al. (2011) +     + 0     +     
39 
Nondahl et al. (2010) 0   + + 
+ 
(abuse) 
- 0 0     
40 Nondahl et al. (2011) 0   0 0 - +   +   0 
41 Oiticica et al. (2015)       0             
42 Park et al. (2014a) 0   0 0 0 0 0 0 0   
43 Park et al. (2014b) 0   0 0 0 0 0 0 0   
44 Park et al. (2018)       0 0 
 
      0 
46 Shargorodsky et al. (2010) +   0 +   0 0       
50 Sogebi (2012) +   0 0 0 +         
52 
Spankovich et al. (2018)     +   
+ 
(abuse) 
          
54 Swan et al. (2017)       +   + +       
55 Yang et al. (2018) 0   + 0     0     0 
 
 
If a significant association was found, this is indicated by ‘+’ (positive) or ‘-‘ (negative).. Insignificant values (absence of association) are 
marked by ‘0’. If a certain risk factor is not investigated by the respective article, the cell is left blank.  
† = only significant association when hypertension and diabetes are present together 
Isch. = ischemic; Periph. Vasc. Disease = peripheral vascular disease; TIA = transient ischemic attack 
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Table 4. Dietary and psychological risk factors. 
M
a
n
u
sc
ri
p
t 
A
u
th
o
rs
 
C
a
ff
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n
e 
H
ea
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h
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 d
ie
t 
D
ep
re
ss
io
n
 
A
n
x
ie
ty
 
S
tr
es
s 
P
o
o
r 
q
u
a
li
ty
 
o
f 
sl
ee
p
 
1 Adoga et al. (2008)     0 0     
2 Axelsson et al. (1989)           0 
3 Bernhardt et al. (2004)     +       
4 Bernhardt et al. (2011)     0       
5 Bhatt et al. (2016)     + +   + 
9 Dorner et al. (2010)         0/+†   
11 Figueiredo et al. (2016) 0           
13 Frederiksen et al. (2017)         0   
18 Glicksman et al. (2014) -           
22 Herr et al. (2016)         +   
23 Hilgenberg et al. (2012)     +       
24 House et al. (2018)     +       
25 Izuhara et al. (2013)           + 
27 Khedr et al. (2010)     + +     
28 Kim et al. (2015)     +   + + 
29 Lasisi et al. (2010)     0       
30 Lasisi et al. (2011)           + 
32 Lee et al. (2017)     +       A
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33 Lin et al. (2018)       +     
35 McCormack et al. (2014) - +         
36 Michikawa et al. (2010)     +       
37 Michikawa et al. (2013)     +       
40 Nondahl et al. (2011)     + 0     
42 Park et al. (2014a)     + 0 0   
44 Park et al. (2018)     +   +   
46 Shargorodsky et al. (2010)     + +     
51 Spankovich et al. (2017)   -         
52 Spankovich et al. (2018)   -         
54 Swan et al. (2017)     0 0   + 
55 Yang et al. (2018)           0 
 
 
If a significant association was found, this is indicated by ‘+’(positive) or ‘-‘ (negative). Insignificant values (absence of association) are 
marked by ‘0’. If a certain risk factor is not investigated by the respective article, the cell is left blank.  
† = positive association for sexual dissatisfaction and discomfort in family/relationship. No significant associations for pressure at work or 
social stress in the workplace.  
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Table 5. Neurological and musculoskeletal risk factors. 
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R
A
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le
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te
n
d
er
n
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p
a
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3 Bernhardt et al. (2004)   +     +     + 
4 Bernhardt et al. (2011)   +     +     0 
12 Folmer et al. (2003) +   +           
19 Gopinath et al. (2010a)     +           
21 
Guichard et al. (2016)   
+ 
(migraine) 
            
23 Hilgenberg et al. (2012)         +       
27 Khedr et al. (2010)   +   0 +       
28 Kim et al. (2015)           + +   
29 Lasisi et al. (2010) +               
31 Lee et al. (2016)         +       
33 Lin et al. (2018) +               
36 Michikawa et al. (2010)               + 
39 Nondahl et al. (2010) 0         +     
40 Nondahl et al. (2011) +         +     A
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43 Park et al. (2014b)         +   +   
45 Pezzoli et al. (2015)   0     0     0† 
49 Sindhusake et al. (2003) + + +     +     
50 Sogebi (2013) 0         0     
52 Spankovich et al. (2018)           +   + 
54 Swan et al. (2017)  + +   + +       
 
If a significant association (positive or negative) was found, this is indicated by ‘+’. Insignificant values (absence of association) are marked by 
‘0’. If a certain risk factor is not investigated by the respective article, the cell is left blank.  
† = only exception: significant positive association between tinnitus and pericranial muscle tenderness 
TMD = temporomandibular joint disorder; RA = rheumatoid arthritis 
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Table 6. Atopic and miscellaneous risk factors. 
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8 Chen et al. (2017)              +                     
14 Frei et al. (2012)                   0               
15 Fujii et al. (2011)   0         0                     
28 Kim et al. (2015) 0 +       0   +                   
29 Lasisi et al. (2010)       +                           
32 Lee et al. (2017)                     +             
33 Lin et al. (2018)                       +           
36 
Michikawa et al. 
(2010) 
            0         
            
38 
Negrila-Mezei et 
al. (2011) 
    + +               
            
42 Park et al. (2014a)     + 0                   0 0 0†   
43 Park et al. (2014b)       +                           
47 Shih et al. (2017)                       +           
48 Shiue et al. (2013)                         +         
49 
Sindhusake et al. 
(2003) 
      +         +     
            
50 Sogebi(2013)                           0‡       
51 
Spankovich et al. 
(2018) 
            0         
      
+ 
    
52 Sunwoo et al.                           0       A
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(2018) 
54 Swan et al. (2017)         +                   +   + 
55 Yang et al. (2018)                   0§           + §   
 
 
 
If a significant association was found, this is indicated by ‘+’. Insignificant values (absence of association) are marked by ‘0’. If a certain risk 
factor is not investigated by the respective article, the cell is left blank.  
† = Hepatitis B 
‡ = sickle cell anemia 
§= duration of cell phone use and fatty liver disease respectively 
TBC = tuberculosis, OSAS = obstructive sleep apnea syndrome 
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